Does a diagnosis of major neurocognitive disorder replace a diagnosis of dementia in geriatric patients with cognitive decline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Major Neurocognitive Disorder vs. Dementia: Terminology and Diagnostic Distinctions

Major neurocognitive disorder (major NCD) is the DSM-5 term that replaces "dementia," but they refer to the same clinical entity—the key difference is nomenclature, not diagnostic criteria. 1, 2, 3

Terminology Evolution

  • The DSM-5 introduced "major neurocognitive disorder" to replace the term "dementia" that was used in DSM-IV, representing a shift in diagnostic language rather than a fundamental change in what is being diagnosed 1, 4

  • This terminology change was designed to be less stigmatizing for patients and families, and to better accommodate neurodegenerative cognitive disorders where memory impairment is not the predominant feature 4

  • In clinical practice, both terms remain in use: "major NCD" appears in formal DSM-5 diagnostic coding, while "dementia" continues to be widely used in clinical guidelines, research literature, and patient communication 2, 3

Core Diagnostic Requirements (Identical Across Both Terms)

Both major NCD and dementia require:

  • Significant cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) 3

  • Functional impairment in everyday activities—the cognitive deficits must interfere with independence in instrumental activities of daily living (IADLs) such as managing finances, medications, transportation, household tasks, cooking, or shopping 5, 6, 3

  • Insidious onset and progressive decline documented through patient/informant history or serial cognitive assessments 5

  • Absence of delirium as the primary explanation for cognitive impairment 5

Key Diagnostic Distinction: Major NCD vs. Mild NCD

The more clinically relevant distinction introduced by DSM-5 is between major and mild neurocognitive disorder:

  • Major NCD (dementia): Cognitive decline that causes loss of independence in everyday functional abilities—patients require assistance with IADLs 1, 7, 3

  • Mild NCD: Noticeable cognitive decline that does not interfere with independence in daily activities, though patients may need to exert compensatory effort or use strategies to maintain function 1, 7

  • Mild NCD corresponds closely to the research concept of mild cognitive impairment (MCI), though the DSM-5 criteria provide more structured diagnostic thresholds 5, 1

Practical Diagnostic Approach

When evaluating cognitive decline, the critical determination is functional status:

  • Obtain collateral history from a reliable informant using validated tools (AD8, IQCODE) to document decline in accustomed activities 6

  • Systematically probe specific IADLs: Can the patient independently manage finances, medications, transportation, household tasks, cooking, and shopping at their previous level? 6

  • If independence is preserved despite cognitive decline → Mild NCD 1, 7

  • If independence is lost and assistance is required → Major NCD (dementia) 5, 7, 3

  • Document objective cognitive impairment in one or more domains using validated instruments (MoCA for comprehensive assessment, complemented by Clock Drawing Test) 5, 6

Clinical Implications

  • The shift to "major NCD" terminology does not change treatment approaches, prognosis discussions, or management strategies—these remain identical to traditional dementia care 2, 3

  • The addition of "mild NCD" as a formal diagnostic category provides a framework for identifying patients at risk for progression who may benefit from closer monitoring and future disease-modifying therapies 1

  • Approximately one-third of patients with mild NCD (particularly multiple-domain subtypes) progress to major NCD within 2 years, while single-domain mild NCD patients may revert to normal 7

Common Pitfalls to Avoid

  • Do not assume the terminology change represents a different disease entity—major NCD and dementia are synonymous 1, 2, 3

  • Do not diagnose major NCD based solely on cognitive test scores without documenting functional impairment in daily activities 6, 3

  • Do not overlook the importance of serial assessments over time to document progressive decline, which distinguishes neurodegenerative disease from static conditions 5, 6

  • Do not attribute acute cognitive changes to major NCD without excluding reversible causes (infections, metabolic disorders, medications, cerebrovascular events) 8

References

Research

Dementia: Dementia Types.

FP essentials, 2023

Research

Dementia.

Annals of internal medicine, 2024

Research

[Mental disorders due to brain lesions in the DSM-5 in the light of the previous versions].

Geriatrie et psychologie neuropsychiatrie du vieillissement, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Differentiating MCI from Dementia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Differential Diagnosis of Sudden Severe Memory Decline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is dementia considered a neurocognitive disorder or a mental illness?
Would a patient with dementia present with just memory fragments?
Is it appropriate to refer an elderly patient with mild dementia to geriatrics for comprehensive assessment and management?
What is the next step for a patient with a diagnosis of mild neurocognitive disorder?
What is the best course of action for an elderly outpatient patient with a history of pneumonia, osteoarthritis, and a neurocognitive disorder, presenting with dementia-like symptoms, confusion, agitation, and aggression?
What is the preferred contraceptive option for a female patient with type 2 diabetes mellitus (T2DM), hypertriglyceridemia, and dyslipidemia: combined hormonal options or progesterone-only options?
When should a low-dose statin (HMG-CoA reductase inhibitor) be added to the treatment regimen of a middle-aged or older adult patient with type 1 or type 2 diabetes mellitus and additional cardiovascular risk factors, such as hypertension, hypercholesterolemia, or a family history of coronary artery disease?
Is myoinositol a viable treatment option for a patient with Obsessive-Compulsive Disorder (OCD)?
What is the recommended dosing for Geodon (ziprasidone) in a patient with schizophrenia or bipolar disorder?
What is the recommended dosage of Augmentin (amoxicillin-clavulanate) for a pediatric patient with a dog bite?
What is the recommended follow-up colonoscopy interval for a patient with a history of 4 adenomas (adenomatous polyps) less than 10 mm and a negative 3-year follow-up colonoscopy, who also has a family history of colon cancer diagnosed at age 65?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.